Peptidotriazolamers Inhibit Abeta(1-42) Oligomerization and Cross a Blood-Brain-Barrier Model
Tonali NM, Hericks L, Schröder DC, Kracker O, Krzemieniecki R, Kaffy J, Le Joncour V, Laakkonen P, Marion A, Ongeri S, Dodero VI, et al. (2021)
ChemPlusChem 86(6): 840-851.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
cplu.202000814.pdf
4.48 MB
Autor*in
Tonali, Nicolo MicheleUniBi;
Hericks, LoreenUniBi;
Schröder, David C.UniBi 
;
Kracker, OliverUniBi;
Krzemieniecki, Radoslaw;
Kaffy, Julia;
Le Joncour, Vadim;
Laakkonen, Pirjo;
Marion, Antoine;
Ongeri, Sandrine;
Dodero, Veronica IsabelUniBi ;
Sewald, NorbertUniBi
Alle
;
Kracker, OliverUniBi;
Krzemieniecki, Radoslaw;
Kaffy, Julia;
Le Joncour, Vadim;
Laakkonen, Pirjo;
Marion, Antoine;
Ongeri, Sandrine;
Dodero, Veronica IsabelUniBi ;
Sewald, NorbertUniBi
Alle
Einrichtung
Abstract / Bemerkung
In peptidotriazolamers every second peptide bond is replaced by a 1H-1,2,3-triazole. Such foldamers are expected to bridge the gap in molecular weight between small-molecule drugs and protein-based drugs. Amyloid beta (Abeta) aggregates play an important role in Alzheimer's disease. We studied the impact of amide bond replacements by 1,4-disubstituted 1H-1,2,3-triazoles on the inhibitory activity of the aggregation "hot spots" K16 LVFF20 and G39 VVIA42 in Abeta(1-42). We found that peptidotriazolamers act as modulators of the Abeta(1-42) oligomerization. Some peptidotriazolamers are able to interfere with the formation of toxic early Abeta oligomers, depending on the position of the triazoles, which is also supported by computational studies. Preliminary in vitro results demonstrate that a highly active peptidotriazolamer is also able to cross the blood-brain-barrier. © 2021 The Authors. ChemPlusChem published by Wiley-VCH GmbH.
Erscheinungsjahr
2021
Zeitschriftentitel
ChemPlusChem
Band
86
Ausgabe
6
Seite(n)
840-851
Urheberrecht / Lizenzen
eISSN
2192-6506
Finanzierungs-Informationen
Open-Access-Publikationskosten wurden durch die Universität Bielefeld im Rahmen des DEAL-Vertrags gefördert.
Page URI
https://pub.uni-bielefeld.de/record/2954394
Zitieren
Tonali NM, Hericks L, Schröder DC, et al. Peptidotriazolamers Inhibit Abeta(1-42) Oligomerization and Cross a Blood-Brain-Barrier Model. ChemPlusChem. 2021;86(6):840-851.
Tonali, N. M., Hericks, L., Schröder, D. C., Kracker, O., Krzemieniecki, R., Kaffy, J., Le Joncour, V., et al. (2021). Peptidotriazolamers Inhibit Abeta(1-42) Oligomerization and Cross a Blood-Brain-Barrier Model. ChemPlusChem, 86(6), 840-851. https://doi.org/10.1002/cplu.202000814
Tonali, Nicolo Michele, Hericks, Loreen, Schröder, David C., Kracker, Oliver, Krzemieniecki, Radoslaw, Kaffy, Julia, Le Joncour, Vadim, et al. 2021. “Peptidotriazolamers Inhibit Abeta(1-42) Oligomerization and Cross a Blood-Brain-Barrier Model”. ChemPlusChem 86 (6): 840-851.
Tonali, N. M., Hericks, L., Schröder, D. C., Kracker, O., Krzemieniecki, R., Kaffy, J., Le Joncour, V., Laakkonen, P., Marion, A., Ongeri, S., et al. (2021). Peptidotriazolamers Inhibit Abeta(1-42) Oligomerization and Cross a Blood-Brain-Barrier Model. ChemPlusChem 86, 840-851.
Tonali, N.M., et al., 2021. Peptidotriazolamers Inhibit Abeta(1-42) Oligomerization and Cross a Blood-Brain-Barrier Model. ChemPlusChem, 86(6), p 840-851.
N.M. Tonali, et al., “Peptidotriazolamers Inhibit Abeta(1-42) Oligomerization and Cross a Blood-Brain-Barrier Model”, ChemPlusChem, vol. 86, 2021, pp. 840-851.
Tonali, N.M., Hericks, L., Schröder, D.C., Kracker, O., Krzemieniecki, R., Kaffy, J., Le Joncour, V., Laakkonen, P., Marion, A., Ongeri, S., Dodero, V.I., Sewald, N.: Peptidotriazolamers Inhibit Abeta(1-42) Oligomerization and Cross a Blood-Brain-Barrier Model. ChemPlusChem. 86, 840-851 (2021).
Tonali, Nicolo Michele, Hericks, Loreen, Schröder, David C., Kracker, Oliver, Krzemieniecki, Radoslaw, Kaffy, Julia, Le Joncour, Vadim, Laakkonen, Pirjo, Marion, Antoine, Ongeri, Sandrine, Dodero, Veronica Isabel, and Sewald, Norbert. “Peptidotriazolamers Inhibit Abeta(1-42) Oligomerization and Cross a Blood-Brain-Barrier Model”. ChemPlusChem 86.6 (2021): 840-851.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung - Nicht kommerziell - Keine Bearbeitungen 4.0 International (CC BY-NC-ND 4.0):
Volltext(e)
Name
cplu.202000814.pdf
4.48 MB
Access Level
Open Access
Zuletzt Hochgeladen
2021-09-27T14:54:08Z
MD5 Prüfsumme
28d71a35a6700bac0fe6107b1ecc905a
Material in PUB:
Teil dieser Dissertation
Conformational Analysis of Peptidotriazolamers and *cyclic* RGD Peptides
Schröder DC (2021)
Bielefeld: Universität Bielefeld.
Schröder DC (2021)
Bielefeld: Universität Bielefeld.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 33905181
PubMed | Europe PMC
Suchen in
Google Scholar